In this sense, the current study not only identifies the role of zyxin in the pathogenesis of macrothrombocytopenia, more importantly, but also suggests that defect of zyxin or other cytoskeleton proteins may have the potential to incur macrothrombocytopenia in humans as well. The gene discussed is ZYX; the disease is Macrothrombocytopenia.